We are live on ! Find out more
APC

Aspire Private Capital Portfolio holdings

AUM $484M
1-Year Est. Return 17.28%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+17.28%
3 Year Est. Return
+49.56%
5 Year Est. Return
+43.58%
10 Year Est. Return
AUM
$210M
AUM Growth
+$974K
Cap. Flow
-$2.95M
Cap. Flow %
-1.4%
Top 10 Hldgs %
41.75%
Holding
592
New
24
Increased
100
Reduced
125
Closed
104
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UL icon
376
Unilever
UL
$137B
$2K ﹤0.01%
24
USB icon
377
US Bancorp
USB
$98.2B
$2K ﹤0.01%
29
WAB icon
378
Wabtec
WAB
$49.1B
$2K ﹤0.01%
31
WPRT
379
Westport Fuel Systems
WPRT
$33.4M
$2K ﹤0.01%
80
DRE
380
DELISTED
Duke Realty Corp.
DRE
-69
Closed -$2.28K
ARNA
381
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2K ﹤0.01%
50
QBAK
382
DELISTED
Qualstar Corp
QBAK
$2K ﹤0.01%
300
CELG
383
DELISTED
Celgene Corp
CELG
$2K ﹤0.01%
18
A icon
384
Agilent Technologies
A
$39.1B
$1K ﹤0.01%
12
ADI icon
385
Analog Devices
ADI
$179B
$1K ﹤0.01%
8
AGNC icon
386
AGNC Investment
AGNC
$12.4B
-234
Closed -$3.84K
ALLE icon
387
Allegion
ALLE
$13.4B
$1K ﹤0.01%
12
BAX icon
388
Baxter International
BAX
$13.5B
$1K ﹤0.01%
16
BBD icon
389
Banco Bradesco
BBD
$39.3B
$1K ﹤0.01%
170
BGS icon
390
B&G Foods
BGS
$287M
$1K ﹤0.01%
38
-148
-80% -$2.84K
GENZ
391
VanEck Digital Native Economy ETF
GENZ
$16.8M
$1K ﹤0.01%
27
-212
-89% -$7.81K
CC icon
392
Chemours
CC
$2.5B
$1K ﹤0.01%
58
CDE icon
393
Coeur Mining
CDE
$15.4B
$1K ﹤0.01%
201
CRBP icon
394
Corbus Pharmaceuticals
CRBP
$166M
$1K ﹤0.01%
7
CRON
395
Cronos Group
CRON
$1.06B
$1K ﹤0.01%
+155
New +$1.98K
CSBR icon
396
Champions Oncology
CSBR
$74.5M
$1K ﹤0.01%
200
-222
-53% -$1.44K
CVS icon
397
CVS Health
CVS
$133B
$1K ﹤0.01%
19
-1,283
-99% -$76K
DOC icon
398
Healthpeak Properties
DOC
$15.1B
-110
Closed -$3.71K
DOV icon
399
Dover
DOV
$27.6B
$1K ﹤0.01%
11
-43
-80% -$4.13K
EPM icon
400
Evolution Petroleum
EPM
$132M
$1K ﹤0.01%
100

Similar funds

Aspire Private Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Aspire Private Capital held 592 positions worth $210M, up 0.47% from $209M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Aspire Private Capital's Q3 2019 filing shows 24 new, 100 increased, 125 reduced and 104 closed positions. Its largest new stake was State Street SPDR Portfolio Europe ETF: 26,294 shares worth $874K. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $7.97M.

By sector, the portfolio is most concentrated in Industrials at 2.3% of assets, up from 2.1% a quarter earlier, followed by Utilities and Consumer Staples.

  • Aspire Private Capital's largest Q3 2019 buy was State Street SPDR Portfolio Europe ETF: 26,294 shares worth $874K.
  • Aspire Private Capital added most to State Street DoubleLine Total Return Tactical ETF in Q3 2019, an estimated $10.9M increase.
  • Aspire Private Capital's biggest Q3 2019 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $7.97M.
  • Aspire Private Capital fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, selling an estimated $1.82M.
  • Aspire Private Capital's ten largest holdings make up 42% of its $210M portfolio in Q3 2019.
  • Aspire Private Capital opened 24 new positions and closed 104 in Q3 2019.
  • Aspire Private Capital's portfolio value rose 0.47% quarter-over-quarter to $210M.

Based on Aspire Private Capital's 13F filing for Q3 2019, filed 12 Nov 2019.